An Arkansas health system is urging state officials to enforce the state’s novel 340B contract pharmacy anti-discrimination law against drug maker Novo Nordisk to end the company’s restrictions on 340B-priced drugs dispensed at multiple contract pharmacies. The lawsuit marks the first time a covered entity has sued under Arkansas Act 1103 and the recently issued Rule 123, which gives effect to the law.
“Contract pharmacy distribution arrangements are not unique to the 340B Program,” White River Medical Center said in a complaint filed Nov. 17 with the Arkansas Insurance Department (AID) and the state’s Insurance Commissioner. “They are a well-established means for non-profit health care providers to dispense drugs to their patients.”
An Arkansas health system is urging state officials to enforce the state’s novel 340B contract pharmacy anti-discrimination law against drug maker Novo Nordisk to end the company’s restrictions on 340B-priced drugs dispensed at multiple contract pharmacies.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
